Drug Trial Radar · NCT05710848
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Last checked: Nov 19, 2026Latest source record: May 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Jul 11, 2023
Primary completion
May 2026
Study completion Aug 2026
Sponsor
- Lead sponsor
- SURGE TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 2, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients with bladder cancer.
Conditions
- Non-muscle-invasive Bladder Cancer
Interventions
STM-416Drug
STM-416 monotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of dose-limiting toxicities (DLTs) [Safety and Tolerability] Phase 1Time frame: 21 days
- Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] Phase 1Time frame: Time on trial up to 90 days
- Recurrence free survival time (Phase 2a)Time frame: Through study completion up to 24 months
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
East Valley Urology Center of Arizona
Mesa, Arizona · Recruiting
Arizona Urology Specialists
Tucson, Arizona · Completed
Arkansas Urology
Little Rock, Arkansas · Recruiting
Unio Specialty Care - A Genesis Healthcare Partners Facility
Bakersfield, California · Recruiting
Genesis Research
Downey, California · Recruiting
Urology Center of Southern California
Murrieta, California · Recruiting
Advanced Urology Institute
Daytona Beach, Florida · Recruiting
University of Florida
Gainesville, Florida · Recruiting
Advent Health
Orlando, Florida · Recruiting
Anna Arundel Urology
Annapolis, Maryland · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Michigan Institute of Urology
Troy, Michigan · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
Carolina Urologic Research Center
Myrtle Beach, South Carolina · Recruiting
Lowcountry Urology
North Charleston, South Carolina · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Urology Partners of North Texas
Fort Worth, Texas · Recruiting
Baylor College of Medicine
Houston, Texas · Recruiting
Houston Methodist
Houston, Texas · Recruiting
University of Texas Health Science Center at San Antonio
San Antonio, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.